Track topics on Twitter Track topics that are important to you
SAN DIEGO, June 29, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has appointed Jim Gibson as Vice President of Operations.
Gibson brings to Kannaway® more than 25 years of experience in global operations positions. His experience includes coordinating the global operations of large scale companies, and being responsible for their worldwide, end-to-end supply chain management and product delivery.
"We are excited to bring Jim on board to the Kannaway® team, as we believe his leadership and his expertise in global forecasting, production and overall business operations will help our Company continue to grow as the sale of CBD products accelerate across the globe," said Kannaway® CEO Blake Schroeder.
"I am eager to make Kannaway® an international brand," said Gibson. "My passion is working with people, and I am excited to begin working with Kannaway® and its Brand Ambassadors at such an exciting time for the Organization as it experiences exponential growth."
Gibson holds a bachelor's degree from Idaho's Boise State University and a MBA from the University of Utah.
For more information on Kannaway®, click HERE to visit the Company website.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSUREMedical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-kannaway-appoints-new-vice-president-of-operations-jim-gibson-300481679.html
SOURCE Medical Marijuana, Inc.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...